Acute generalized exanthematous pustulosis following treatment with
remdesivir in a patient with SARS-CoV-2 infection, a case report

Abstract

We hereby, present the first case of Acute generalized exanthematous
pustulosis (AGEP) following treatment with remdesivir in a patient with
COVID-19 without hydroxychloroquine use which serves as a reminder for
considering remdesivir as a possible causative agent when dealing with
AGEP presentation in COVID patients.



Source link